| Identification | |
| Name: | mechlorethamine hydrochloride |
| Synonyms: | chlormethine hydrochloride; Chloromethine Hydrochloride; nitrogen mustard hydrochloride; N-methyl-bis(2-chloroethyl)amine hydrochloride; |
| CAS: | 55-86-7 |
| EINECS: | 200-246-0 |
| Molecular Formula: | C5H11Cl2N?HCl |
| Molecular Weight: | 192.51 |
| InChI: | InChI=1/C5H11Cl2N.ClH/c1-8(4-2-6)5-3-7;/h2-5H2,1H3;1H |
| Molecular Structure: |  |
| Properties | |
| Transport: | UN 2811 |
| Density: | 1.106g/cm3 |
| Stability: | Stable. Hygroscopic. |
| Refractive index: | 1.4689 (24 C) |
| Solubility: | Soluble |
| Appearance: | white crystalline powder |
| Specification: |
Bis(2-chloroethyl)methylaminehydrochloride (CAS NO.55-86-7) is also named as Chlormethine hydrochloride ; 1,5-Dichloro-3-methyl-3-azapentanehydrochloride ; 2-Chloro-n-(2-chloroethyl)-n-methylethanaminehydrochlroide ; 2-Chloro-n-(2-chloroethyl)-n-methyl-ethanaminhydrochloride ; Antimit ; Azotoyperite ; Beta,beta'-dichlorodiethyl-n-methylaminehydrochloride ; C6866 ; Caryolysine and so on. Bis(2-Chloroethyl)Methylamine Hydrochloride is usually white to off-white crystals or powder with a fishy odor. |
| Report: |
NTP 10th Report on Carcinogens. IARC Cancer Review: Group 2A IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man 7 (1987),p. 269.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man 9 (1975),p. 193.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . EPA Genetic Toxicology Program. |
| Packinggroup: | II |
| Color: | Mobile liquid Dark liquid Liquid, colorless/pale yellow when fresh [Munro NB et al; Environ Health Perspect 107: 933-973 (1999)] PubMed Abstract |
| Usage: | Prototype anticancer chemotherapeutic drug. Formerly used as a war gas. |
| Safety Data | |
| Hazard Symbols |
T+:Verytoxic
|
 |
|
